Research programme: pineapple protease chemotherapy - Medical Marketing International

Drug Profile

Research programme: pineapple protease chemotherapy - Medical Marketing International

Alternative Names: Pineapple protease

Latest Information Update: 04 May 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Provalis
  • Developer Medical Marketing International Group
  • Class Peptides
  • Mechanism of Action Protein modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 04 Sep 2009 Discontinued - Preclinical for Cancer in United Kingdom (unspecified route)
  • 16 Aug 2007 Preclinical development is ongoing
  • 20 Nov 2001 Provalis has licensed its pineapple protease research programme to Medical Marketing International
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top